Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.Background.Darbepoetin
Background: The optimal hemoglobin target and possible toxicity of epoetin therapy in hemodialysis patients are controversial.Previous studies suggest that Afri